BPC-157, in particular, has demonstrated protective effects against NSAID-induced gastric damage and may act on nitric oxide pathways to maintain vascular homeostasis
Concentration: 1% GHK-Cu (clinically validated range) Volume: 3mL, approximately 60 applications Price: $29.99 Format: Ready-to-use, no reconstitution Purity: 99%+ HPLC-verified with batch-specific COA Manufacturing: US-based, third-party tested PSPeptides also carries lyophilized GHK-Cu vials for researchers requiring the injectable format, plus two multi-peptide blends that include GHK-Cu: the GLOW Blend (BPC-157 + GHK-Cu + TB-500) and the KLOW Blend (adds KPV)
The primary assumptions were that BPC-157 is highly stable, biocompatible, and sufficient to exert action when presented by itself
In rats given BPC-157, serotonin levels in the brain increase in specific regions while simultaneously decreasing in other regions, such as the hippocampus.[ref] A 2020 study found that BPC-157 reduced leaky gut syndrome by stabilizing gut permeability after NSAID use.[ref] Reducing leaky gut theoretically can affect the gut-brain axis and reduce inflammation